Generic drugs for developing nations

Consumption in Developing Nations

Developing drugs for developing countries.

Infectious and parasitic diseases create enormous health burdens, but because most of the people suffering from these diseases are poor, little is invested in developing treatments. We propose that developers of treatments for neglected diseases receive a "priority review voucher." The voucher could save an average of one year of U.S. Food and Drug Administration (FDA) review and be sold by the...

Estimating the market for tuberculosis drugs in industrialized and developing nations.

BACKGROUND The successful introduction of new drugs into low- and middle-income countries requires an understanding of the existing market size and market dynamics for the therapeutic area of interest. The drug markets in these countries are, however, less well understood than those in high-income countries. METHODS The global market for tuberculosis (TB) drugs was estimated by studying in de...

Elimination of Waste and Inefficient Facilities in Existing Buildings for Sustainability in Developing Nations

A major reason why many developing nations have not made significant advancement in sustainable development (SD) agenda is the neglect of existing building stock which forms the bulk of built assets. Although sustainable development is a universal challenge, it cannot be approached in the same way for all nations, but rather practical response can be defined nationally or locally. This paper re...

An Inexpensive Scheffler Reflector for Developing Nations